TropD-Detector: A CRISPR/LbCas12a-Based system for rapid and sensitive screening of Trypanosoma cruzi in Chagas vectors and reservoirs

Read the full article See related articles

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Chagas disease, also known as American Trypanosomiasis, is a zoonosis with global distribution caused by the parasite Trypanosoma cruzi , primarily transmitted through the feces of infected triatomines. The emergence of new cases in non-endemic areas highlights the importance of early pathogen detection in vectors and reservoirs to generate effective control strategies and establish preventive policies. The objective of this study was to design and validate a detection system of T. cruzi based on specific DNA cleavage and collateral activation using the CRISPR/LbCas12a system, targeting the genes Cytochrome B ( Cytb ), 18S ribosomal subunit ( SR18s ), and histone ( H2A ). This system was validated for their uses in both vectors and reservoirs of the parasite. The first step was to conduct a bioinformatic analysis of the target genes and design RNA guides for each cleavage site and primers to amplify the target region through PCR. Subsequently, we sequenced the amplified DNA target and validated the detection system using T. cruzi DNA extracted from naturally infected Rhodnius pallescens in the metropolitan area of Bucaramanga, Colombia. After standardizing the method, we tested the CRISPR/Cas system with Silvio X10/4 laboratory strain of T. cruzi and scaled up to blood samples of naturally infected Didelphis marsupialis . As a result, we observed the DNA cleavage employing the CRISPR/Cas system with Cytb guide with a sensitivity of up to 0.0475 ng/uL of provided DNA. Sequencing of the Cytb gene showed no mutations in the cleavage site. However, point mutations and indels were found in SR18S and H2A , avoiding the formation of the CRISPR/LbCas12 complex. Furthermore, we introduce the design of a fluorescent detection prototype with CRISPR/LbCas12a called “Tropical Diseases Detector” (TropD-Detector). This device operates with an excitation wavelength of 480 nm emitted by an LED and a high-pass light filter with a cutoff wavelength of 500 nm. We detected positive samples using any photographic camera system. The TropD-Detector provides a visual, viable, and sensitive method for detecting T. cruzi in both vectors and reservoirs from endemic areas.

Article activity feed